← Back to Clinical Trials
Recruiting NCT06777771

NCT06777771 Effects of Reformer Pilates in Pregnant Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06777771
Status Recruiting
Phase
Sponsor Izmir Democracy University
Condition Pregnancy Related
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-02-06
Primary Completion 2025-08

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Reformer pilates exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-02-06 with a primary completion date of 2025-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pregnancy is known as a period associated with important physiological and psychological changes in women's lives. There is moderately sufficient evidence in the literature to recommend supplementing prenatal physical activity for maternal health benefits. It has been reported that physical exercise by pregnant women in the absence of obstetric contraindications will not pose a risk to the health of the mother and fetus. In the literature, there are no studies examining the effects of reformer pilates on pain, functional capacity, lumbopelvic stabilization, diastasis recti abdominis, abdominal muscle thickness, respiratory functions, pelvic floor dysfunction, urinary incontinence, sexual function, and venous insufficiency in pregnant women. Therefore, this study aimed to investigate the effects of reformer pilates on pain, functional capacity, lumbopelvic stabilization, diastasis recti abdominis, abdominal muscle thickness, respiratory functions, pelvic floor dysfunction, urinary incontinence, sexual function, and venous insufficiency in pregnant women.

Eligibility Criteria

Inclusion Criteria: * Single pregnancy * Primiparous pregnancy * Adult pregnant women (between 18-35 years old) * Pregnant women whose gestational week is 11-22 weeks * Pregnant women with a body mass index \<30 * Ability to read and write Exclusion Criteria: * Multiple pregnancies * Having a history of abdominal surgery * Having one of the conditions in which exercise is contraindicated, such as heart disease, severe lung disease, continuous bleeding in the second and third trimesters, placenta previa, risk of premature birth, rupture of membranes, preeclampsia, severe anemia * Not volunteering to participate in the study * Not participating in more than 90% of the training sessions

Contact & Investigator

Central Contact

Özlem Çinar Özdemir, Prof.Dr.

✉ ozlemcinarozdemir@gmail.com

📞 +90 232 299 0733

Principal Investigator

Özlem Çinar Özdemir, Prof.Dr.

STUDY DIRECTOR

Izmir Democracy University

Frequently Asked Questions

Who can join the NCT06777771 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06777771 currently recruiting?

Yes, NCT06777771 is actively recruiting participants. Contact the research team at ozlemcinarozdemir@gmail.com for enrollment information.

Where is the NCT06777771 trial being conducted?

This trial is being conducted at Izmir, Turkey (Türkiye).

Who is sponsoring the NCT06777771 clinical trial?

NCT06777771 is sponsored by Izmir Democracy University. The principal investigator is Özlem Çinar Özdemir, Prof.Dr. at Izmir Democracy University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology